JESSICA MYERS: Open Payments
NPI 1902278476 · SULLIVAN, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$897 in 38 payments from 16 companies in 2025. Trend: 2023 $2,451 · 2024 $659 · 2025 $897
Food & beverage: $897
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $135 |
| Medtronic, Inc. | 1 | $121 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $89 |
| HARMONY BIOSCIENCES LLC | 3 | $73 |
| Vanda Pharmaceuticals Inc. | 2 | $70 |
| Alkermes, Inc. | 3 | $60 |
| Janssen Pharmaceuticals, Inc | 2 | $60 |
| Axsome Therapeutics, Inc. | 2 | $54 |
| Electromed, Inc. | 7 | $43 |
| JAZZ PHARMACEUTICALS INC. | 1 | $36 |
Products named: VRAYLAR, INVOS, CAPLYTA, WAKIX, FANAPT, SPRAVATO, Auvelity, SMARTVEST.
Industry payments across IN — which companies pay providers there.
